Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Neurotransmitter receptor
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Metabotropic receptors: G-protein coupled receptors== [[Image:Mu-opioid receptor (GPCR).png|thumb|A [[opioid receptor|mu-opioid G-protein-coupled receptor]] with its agonist]] '''[[G protein-coupled receptors]]''' ('''GPCRs'''), also known as '''seven-transmembrane domain receptors''', '''7TM receptors''', '''heptahelical receptors''', '''serpentine receptor''', and '''G protein-linked receptors''' ('''GPLR'''), comprise a large [[protein]] family of [[membrane receptor|transmembrane receptor]]s that sense [[molecule]]s outside the [[Cell (biology)|cell]] and activate inside [[signal transduction]] pathways and, ultimately, cellular responses. G protein-coupled receptors are found only in [[eukaryote]]s, including yeast, [[choanoflagellate]]s,<ref name="pmid12869759">{{cite journal |vauthors=King N, Hittinger CT, Carroll SB | title = Evolution of key cell signaling and adhesion protein families predates animal origins | journal = Science | volume = 301 | issue = 5631 | pages = 361–3 | year = 2003 | pmid = 12869759 | doi = 10.1126/science.1083853 | bibcode = 2003Sci...301..361K | s2cid = 9708224 }}</ref> and animals. The [[Ligand (biochemistry)|ligands]] that bind and activate these receptors include light-sensitive compounds, [[odor]]s, [[pheromone]]s, [[hormone]]s, and [[neurotransmitter]]s, and vary in size from small molecules to [[peptide]]s to large [[protein]]s. G protein-coupled receptors are involved in many diseases, and are also the target of approximately 30% of all modern medicinal drugs.<ref>{{cite journal | first=David | last=Filmore | pages=24–28 | title=It's a GPCR world | journal=Modern Drug Discovery | volume=2004 | year=2004 | issue=November | url=http://pubs.acs.org/subscribe/journals/mdd/v07/i11/html/1104feature_filmore.html}}</ref><ref name="pmid17139284">{{cite journal |vauthors=Overington JP, Al-Lazikani B, Hopkins AL | title = How many drug targets are there? | journal = Nat Rev Drug Discov | volume = 5 | issue = 12 | pages = 993–6 |date=December 2006 | pmid = 17139284 | doi = 10.1038/nrd2199 | s2cid = 11979420 }}</ref> There are two principal signal transduction pathways involving the G protein-coupled receptors: the [[Cyclic adenosine monophosphate|cAMP]] signal pathway and the [[phosphatidylinositol]] signal pathway.<ref name="Gilman A.G. 1987 615–649">{{cite journal | author = Gilman A.G. | title = G Proteins: Transducers of Receptor-Generated Signals | journal = Annual Review of Biochemistry | year=1987 | volume=56 | pages=615–649 | doi = 10.1146/annurev.bi.56.070187.003151 | pmid = 3113327| s2cid = 33992382 }}</ref> When a ligand binds to the GPCR it causes a conformational change in the GPCR, which allows it to act as a [[guanine nucleotide exchange factor]] (GEF). The GPCR can then activate an associated [[G-protein]] by exchanging its bound [[guanosine diphosphate|GDP]] for a [[guanosine triphosphate|GTP]]. The G-protein's α subunit, together with the bound GTP, can then dissociate from the β and γ subunits to further affect intracellular signaling proteins or target functional proteins directly depending on the α subunit type ([[Gαs|G<sub>αs</sub>]], [[Gαi|G<sub>αi/o</sub>]], [[Gαq|G<sub>αq/11</sub>]], [[G12/G13 alpha subunits|G<sub>α12/13</sub>]]).<ref name="Wettschureck_2005">{{cite journal |vauthors=Wettschureck N, Offermanns S | title = Mammalian G proteins and their cell type specific functions | journal = Physiol. Rev. | volume = 85 | issue = 4 | pages = 1159–204 |date=October 2005 | pmid = 16183910 | doi = 10.1152/physrev.00003.2005 | s2cid = 24270725 }}</ref>{{rp|1160}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)